Teza Capital Management LLC Reduces Holdings in Teladoc Health, Inc. $TDOC

Key Points

• Teza Capital Management LLC significantly reduced its stake in Teladoc Health, selling 43,316 shares and trimming its position by 77.2% in the first quarter, now holding only 12,825 shares valued at approximately $102,000.
• Several institutional investors have increased their holdings in Teladoc Health, with Point72 Asset Management L.P. boosting their position by 33.6%, acquiring over 2.8 million additional shares.
• Analysts are mixed on Teladoc Health's stock, with an average rating of "Hold" and price targets ranging from $7.00 to $10.00, as the company faces challenges reflected in its recent earnings report.

Teza Capital Management LLC trimmed its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 77.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,825 shares of the health services provider's stock after selling 43,316 shares during the period. Teza Capital Management LLC's holdings in Teladoc Health were worth $102,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the business. NewEdge Advisors LLC grew its stake in Teladoc Health by 1,278.7% in the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock valued at $90,000 after acquiring an additional 10,485 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Teladoc Health by 2.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider's stock valued at $1,542,000 after acquiring an additional 5,235 shares during the last quarter. Invenomic Capital Management LP boosted its stake in shares of Teladoc Health by 36.3% during the 1st quarter. Invenomic Capital Management LP now owns 1,327,128 shares of the health services provider's stock worth $10,564,000 after purchasing an additional 353,478 shares during the last quarter. Chiron Capital Management LLC boosted its stake in shares of Teladoc Health by 92.1% during the 1st quarter. Chiron Capital Management LLC now owns 65,505 shares of the health services provider's stock worth $521,000 after purchasing an additional 31,400 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in shares of Teladoc Health by 40.7% during the 1st quarter. Canada Pension Plan Investment Board now owns 321,800 shares of the health services provider's stock worth $2,562,000 after purchasing an additional 93,100 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Truist Financial decreased their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday, May 27th. Bank of America decreased their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Evercore ISI raised their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Finally, Mizuho assumed coverage on shares of Teladoc Health in a research note on Friday, July 25th. They set a "neutral" rating and a $10.00 price target on the stock. Six equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, Teladoc Health has a consensus rating of "Hold" and an average target price of $9.80.

Teladoc Health Stock Up 0.1%

Shares of TDOC traded up $0.01 during mid-day trading on Monday, reaching $7.69. 671,752 shares of the stock traded hands, compared to its average volume of 6,711,048. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of -6.45 and a beta of 1.84. The stock has a fifty day simple moving average of $7.71 and a 200 day simple moving average of $7.67. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business's quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Sell-side analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.